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THE MECtWNIS!4 OF CARDIOVASCULAE EFFECZS OF NEUROPEPTIDE Y 
REQUIRES AN INTACT C PROTEIN SYSTEM: DEMONSTRATION BY 
PERTUSSIS TOXIN IN DOGS, fN VIVO. 
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a given 48 hr before acute open chest 
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each variable: 
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arterial vaso- 
conrtrfctfon. Ue conclude that the coronary constrictor, 
varopresrot and negative chronotropfc bradycardic effects 
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EFFECT OF NEURCPEPTIDE Y ON ISOLATED RAT HEARTS 
Stanley Ft. Jolly, kshia Ordoukani, 
University, Greenville, NC 
Assad Movahed, East Carolina 
Neuropeptide Y (NPY) Induces coronary vasoconstrlction and an 
associated negative lnotropic effect In the Isolated rat heart, but it is 
unclear whether NPY produces these effects directly or through the 
medlation of other vasoactive substances. This problem has been 
examined in Langendorff-perfused, paced hearts using constant 
pressure. In 22 dose-response experiments, NPY, 0.05 to 5 nmol, 
produced dose dependent reduction of flow 
A dose of 0.5 nmol NPY, approximately 5 X 1 
further studies. l’hls dose reduced coronary flow by 22&S%, and 
developed pressure by -14~5 (meaniS0). NPY was examined during 
Infusion of the lndomethaoln (n=6) and the 5 lipoxygenase Inhibitor 
RG6666 (N-methyl+benzyloxyphenyl acetohydroxamlc acid, n=6), 
using a test dose for both agents of 20 Ag/mln (approximately 3 PM) or 
vehicle (ethanol, O.@l ml/min, n=9). Ethanol vehicle did not change 
developed pressure, coronary flow or responses to NPY, 0.5 nmol. 
NPY reduced coronary flow In all three groups: vehicle 9.7A3.3 to 
7.3t2.5 mumin, indomethacln 12.623.6 to 10.4k3.3, and RG6666 
6.2i2.7 to 7.5i2.5; reductions of 25+7,19iS and 13&9%, 
respectively. The flow reduction % was attenuated by RG6666. 
Developed pressure was slgnlficantly reduced by NPY in vehicle 71210 
to 62211 mm Hg, and indomethacin 7OtlO to 64=ll but not FIG6666 
742 15 to 71 f 15 groups, reductions of 13*3, Q&Q and 4*5%, 
respectivety. In conclusion, ne Y produces significant 
coronary vasooonstriotlon and reduction in developed 
pressure. These effects did not appear to be mediated by 
qolooxygenase products. A potential contribution by S-lipoxygenase 
products in this response deserves further Investigation. 
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DIFFERENT INTERACTION OF TS WITH ARTERIAL AN 
VENOUS CORONARY BYPASS ROLE OF NITRIC OXID 
AND ANTIPLATELET DRUGS 
Ludwig von Segesser, Erwin Bauer, Peter Stult, 
homas F. Liischer. Depts. of Medicine and Research 
University Hospitals, Base1 and Zurich, Swi~~rland 
Platelet-vessel wall interactions are important for vascular function. 
We studied human platelets in internal mammary artery (IMA) and 
saphenous vein (SV) suspended in organ chambers for isometric 
tension recording. In IMA contracted with norepinephrine, Platelets 
(1,000.75,OOO/pl) induced endothelium-dependent relaxations 
(64&5%) prevented by apyrase or L-No-monomethyl arginine. In 
contrast, in SV, platelets induced contractions (61&35%) facilitated 
by endothelium (153&20%; 05). In quiescent IMA, platelets 
induced a small contraction KCI 100 rn~) which was 
enhanced by endothelium re 6%; pcO.05). In quiescent 
SV, platelets it?:duced more pronounced csntractions (56flO%) than 
in IMA (peO.05) which were reduced by endothelium removal or 
indomethacin. In IMA and SV, contractions to platelets were 
prevented by the thromboxane antagonist, SO30741 plus the 
serotonin antagonist, ketanserin. Treatment of platelets with aspirin 
inhibited contractions in IMA and to a lesser extent in SV. Thrombin 
(1 U/ml) induced a pronounced additional platelet-induced 
contraction (30&S%) in IMA without endothelium which was 
prevented in rings with endothelium (3&2%; p<O.O05). 
Thus, the arterial, but not venous endothelium, inhibits 
platelet-vessel wall interaction by releasing nitric oxide in response 
to ADP and thrombin. Platelet-derived thromboxane A2 and 
serotonin mediate potent contractions in SV and less in IMA, which 
are prevented by specific receptor antagonists.This may explain the 
different graft function of IMA and SV and the clinical efficacy of 
antiplatelet drugs. 
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OXIDIZED. BUT NOT NATIVE LOW DENSITY LIPOPROTEINS 
INHIBIT RELAXATIONS OF PORCINE CORONARY ARTERIES 
BY A SCAVENGER RECE R DEPENDENT SM: ROLE 
OF END -DERIVE 
, Chantal M. Boulanger, and Thomas F. Ltischer 
Departement of Research, Laboratory of Vascular Research, University 
Hospital, CH-403 1 Base1 
The study was designed to investigate the invo’qement of low density 
lipoproteins (LDL) in endothelium dysfunction in atherosclerosis. 
Porcine coronary artery rings suspended in organ chambers for isometric 
tension recording were exposed to LDL for 2 hours. Oxidized, but not 
native LDL inhibited endotheliumdependent relaxations to aggregating 
platelets (5OOO-~SOOO/J.@, serotonin and thrombin in a dose-dependent 
manner from 30 to 300 @ml. Neither endothelium-dzpendent rela- 
xations to the calcium ionophore A 23187 nor endothelium-independent 
relaxations lo SIN-l were affected by ox LDL indicating that its effect is 
related to receptor-operated mechanisms leading to the formation of 
endothelium-derived relaxing factor. Endothelium-dependent relaxations 
to bradykinin, however, were nut inhibited by ox LDL. Since 
L-NG-monomethyl arginine, methylene blue and hemoglobin as well as 
ox LDL markedly reduced the relaxations to serotonin,but not those lo 
bradyklnin, ox LDL must interfen with the formation of the endogenous 
nitrate. In line with that interpretation arteries treated with ox LDL 
completely relaxed to L-arginine (3x10AM), but not D-arginine when the 
aminoacid was added on top of the relaxation to serotonin. Dysfunction 
of 8 pertussis toxin sensitive Cl protein can be excluded since the 
inhibitory effect of ox LDL persisted in the presence of pertussis toxin. 
The effect of ox LDL could be completely prevented by dextran sulfate 
(lOpg/ml) indicating that it involves activation of the scavenger receptor. 
Thus, ox LDL inhibit the receptor-operated nitric oxide formation by 
activating the scavenger recepror on endothelial cells. The reduced nitric 
oxide formation at sites of early atherosclerotic lesions may favour 
platelet aggregation and vasospasm, both known clinical events in 
patients with coronary artery aisease. 
